Sample information curated by ChIP-Atlas

Antigen

Antigen Class
RNA polymerase
Antigen
RNA polymerase II

Cell type

Cell type Class
Pluripotent stem cell
Cell type
Embryoid Bodies
MeSH Description
Spontaneous aggregations of human embryonic stem cells that occur in vitro after culturing in a medium that lacks LEUKEMIC INHIBITORY FACTOR. The embryoid bodies can further differentiate into cells that represent different lineages.

Attributes by original data submitter

Sample

source_name
E14Tga2.mESC derived Embryoid bodies
genotype
Wild type
tissue
CRL-1821 cell line
chip antibody
RNAPII, Santa Cruz, #sc-899

Sequenced DNA Library

library_strategy
ChIP-Seq
library_source
GENOMIC
library_selection
ChIP
library_construction_protocol
For ChIP-seq, nuclei was isolated from cells fixed with 1% Formaldehyde. Next, chromatin was fragmented into ~250bp. Chromatin immunoprecipitation was performed with the indicated antibodies. For RNA-seq, total RNA was isolated with RNAeasy (Qiagen) and reverse transcribed using Superscript III and random hexamers (Life Technologies) to synthesize the 1st strand. Second strand was synthesized with dUTP to generate strand asymmetry using DNA Pol I (NEB, M0209L) and the E. coli ligase (Enzymatics, L6090L). For ChIP-seq and RNA-seq, libraries were prepared by standard protocol. First, fragments are repaired to generate blunt 5' P ends using 'EndIT DNA End Repair kit' (Epicentre). Second, 3' A overhang was generated using 'Klenow Fragment (3´→ 5´ exo-)' (NEB). Third, Illumina barcodes were ligated using 'Rapid T4 DNA Ligase' (Enzymatics). Lastly, libraries were size selected using 'Ampure beads' (Beckman Coulter), then amplified, quantified and pooled.

Sequencing Platform

instrument_model
Illumina HiSeq 2500

mm10

Number of total reads
41708264
Reads aligned (%)
82.3
Duplicates removed (%)
9.6
Number of peaks
10566 (qval < 1E-05)

mm9

Number of total reads
41708264
Reads aligned (%)
82.2
Duplicates removed (%)
9.6
Number of peaks
10575 (qval < 1E-05)

Base call quality data from DBCLS SRA